Sharps Technology, Inc. (NASDAQ:STSS) Short Interest Up 52.9% in April

Sharps Technology, Inc. (NASDAQ:STSS) was the target of a large growth in short interest in April. As of April 15th, there was short interest totalling 352,700 shares, a growth of 52.9% from the March 31st total of 230,600 shares. Currently, 2.5% of the company’s stock are sold short. Based on an average daily volume of 180,500 shares, the days-to-cover ratio is currently 2.0 days.

Sharps Technology Stock Performance

Shares of Sharps Technology stock remained flat at $0.29 during midday trading on Friday. 14,955 shares of the stock were exchanged, compared to its average volume of 77,862. The firm has a 50 day moving average of $0.33 and a 200 day moving average of $0.38. Sharps Technology has a fifty-two week low of $0.27 and a fifty-two week high of $1.58.

Sharps Technology (NASDAQ:STSS) last released its quarterly earnings results on Friday, March 29th. The company reported ($0.16) earnings per share for the quarter.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Sharps Technology stock. Compass Ion Advisors LLC purchased a new position in Sharps Technology, Inc. (NASDAQ:STSS) during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm purchased 57,143 shares of the company’s stock, valued at approximately $32,000. Compass Ion Advisors LLC owned about 0.49% of Sharps Technology at the end of the most recent reporting period. Institutional investors and hedge funds own 17.17% of the company’s stock.

About Sharps Technology

Sharps Technology, Inc, a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc was incorporated in 2017 and is based in Melville, New York.